Moderna Shares Double on Success of mRNA Cancer Vaccine wsj.comModerna and Merck shares soar on mRNA cancer vaccine AxiosModerna, Merck cancer vaccine shows promise in late-stage trial; Moderna stock soars 177% CNBCModerna’s 160% Surge Burns Shorts in ‘Painful’ $5 Billion Loss BloombergModerna stock surges as melanoma vaccine trial shows "landmark moment" Yahoo Finance